DNA X, Inc. (SONM)
Official siteFINANCIAL SERVICES • COMMUNICATION EQUIPMENT • NASDAQ
Market Cap: $3.23M
Last updated: Nov 17, 2026 at 11:02 AM ET
DNA X, Inc. (SONM) Earnings: Report Dates and Results
DNA X (SONM) is expected to report earnings on Apr 12, 2027. In the quarter ended Sep 30, 2026, DNA X reported EPS of -$3.86. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
SONM has an expected report date of Apr 12, 2027.
Earnings History
Of the 22 quarters below that had an estimate, SONM beat 9 and missed 13. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 400.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$3.86 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 | N/A |
| Jun 30, 2026 | -$1.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 19, 2026 | N/A |
| Mar 31, 2026 | $5.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 20, 2026 | N/A |
| Sep 30, 2025 | -$4.83 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | Oct 31, 2025 | $16.21M |
| Jun 30, 2025 | -$0.79 | $0.04 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$4.34 | $0.04 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Apr 2, 2025 | N/A |
| Dec 31, 2024 | -$4.42 | $0.03 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2025 | N/A |
| Sep 30, 2024 | -$9.36 | -$11.88 | N/A | +21.21% | Beat | -76197.6% | 1 | 0 up, 0 down | Nov 13, 2024 | $15.02M |
| Jun 30, 2024 | -$25.38 | -$9.72 | N/A | -161.11% | Miss | N/A | 1 | 0 up, 0 down | Aug 9, 2024 | $11.52M |
| Mar 31, 2024 | -$12.60 | -$5.40 | -$5.40 - -$5.40 | -133.33% | Miss | N/A | 1 | 0 up, 0 down | May 14, 2024 | $16.78M |
| Dec 31, 2023 | -$0.03 | $0.01 | $0.01 - $0.01 | -400.00% | Miss | N/A | 1 | 0 up, 0 down | Mar 27, 2024 | $13.43M |
| Sep 30, 2023 | $0.01 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Nov 14, 2023 | $27.57M |
| Jun 30, 2023 | -$1.31 | -$0.70 | N/A | -87.14% | Miss | N/A | N/A | 0 up, 0 down | Aug 14, 2023 | $26.84M |
| Mar 31, 2023 | -$1.31 | -$0.70 | N/A | -87.14% | Miss | N/A | N/A | 0 up, 0 down | May 8, 2023 | $25.80M |
| Dec 31, 2022 | -$0.03 | -$0.10 | N/A | +74.40% | Beat | N/A | N/A | 0 up, 0 down | Mar 20, 2023 | $24.12M |
| Sep 30, 2022 | -$0.04 | -$0.20 | N/A | +80.00% | Beat | N/A | N/A | N/A | Nov 14, 2022 | $20.50M |
| Jun 30, 2022 | -$0.22 | -$0.30 | N/A | +26.67% | Beat | N/A | N/A | N/A | Aug 12, 2022 | $11.96M |
| Mar 31, 2022 | -$0.38 | -$0.50 | N/A | +24.00% | Beat | N/A | N/A | 0 up, 0 down | May 10, 2022 | $13.26M |
| Dec 31, 2021 | -$0.37 | -$0.45 | N/A | +17.78% | Beat | N/A | N/A | 0 up, 0 down | Mar 21, 2022 | $15.93M |
| Sep 30, 2021 | -$235.80 | -$108.00 | N/A | -118.33% | Miss | N/A | 1 | N/A | Nov 10, 2021 | $14.45M |
| Jun 30, 2021 | -$180.00 | -$162.00 | -$215.83 - -$161.87 | -11.11% | Miss | N/A | 3 | N/A | Aug 16, 2021 | $11.95M |
| Mar 31, 2021 | -$252.00 | -$171.00 | N/A | -47.37% | Miss | N/A | 3 | N/A | May 11, 2021 | $12.24M |
| Dec 31, 2020 | -$0.50 | -$1.37 | -$2.10 - -$1.00 | +63.50% | Beat | N/A | 3 | N/A | Mar 10, 2021 | $15.84M |
| Sep 30, 2020 | -$180.00 | -$702.00 | N/A | +74.36% | Beat | N/A | 3 | N/A | Nov 11, 2020 | $14.39M |
| Jun 30, 2020 | -$267.12 | -$504.00 | -$539.57 - -$413.67 | +47.00% | Beat | N/A | 3 | N/A | Aug 12, 2020 | $21.06M |
| Mar 31, 2020 | -$4.80 | -$2.75 | -$3.00 - -$2.50 | -74.55% | Miss | N/A | 2 | N/A | May 14, 2020 | $12.71M |
| Dec 31, 2019 | -$564.17 | -$162.00 | -$791.37 - $35.97 | -248.25% | Miss | -331964.7% | 4 | N/A | Mar 11, 2020 | $17.17M |
| Sep 30, 2019 | -$297.90 | $243.00 | N/A | -222.59% | Miss | N/A | 4 | N/A | Oct 30, 2019 | $28.85M |
| Jun 30, 2019 | -$87.66 | $72.00 | N/A | -221.75% | Miss | N/A | 3 | N/A | Jul 24, 2019 | $43.75M |
| Mar 31, 2019 | -$3.90 | -$2.90 | -$2.90 - -$2.90 | -34.48% | Miss | N/A | 1 | N/A | Jun 24, 2019 | $26.48M |
| Dec 31, 2018 | $0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 27, 2019 | $46.53M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$51.76, after -$2.64 the year before. It was $0.17 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$51.76 | N/A |
| Dec 31, 2023 | -$2.64 | N/A |
| Dec 31, 2022 | -$0.67 | N/A |
| Dec 31, 2021 | -$668.17 | N/A |
| Dec 31, 2020 | -$452.42 | N/A |
| Dec 31, 2019 | -$953.63 | -561058.8% |
| Dec 31, 2018 | $0.17 | N/A |
Frequently Asked Questions About SONM
When is DNA X's next earnings date?
DNA X's next earnings report is expected for Apr 12, 2027.
How often does SONM beat earnings estimates?
DNA X beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -86.64%.
SONM pages: Overview, Earnings, Financials, Competitors